Doctors discuss use of MenB vaccine at Princeton University

January 5, 2014
Doctors discuss use of MenB vaccine at princeton university
The planned use of an experimental Neisseria meningitides serogroup B meningitis vaccine at the University of Princeton has raised several contentious issues relating to vaccination, according to an ideas and opinions piece published online Dec. 24 in the Annals of Internal Medicine.

(HealthDay)—The planned use of an experimental Neisseria meningitides serogroup B (MenB) meningitis vaccine at the University of Princeton has raised several contentious issues relating to vaccination, according to an ideas and opinions piece published online Dec. 24 in the Annals of Internal Medicine.

Kristen A. Feemster, M.D., M.P.H., and Paul Offit, M.D., from the University of Pennsylvania School of Medicine in Philadelphia, discuss use of the unlicensed (Bexsero) at the University of Princeton, where eight confirmed cases of MenB have been identified.

The authors note that despite a coordinated response from the University, N.J. Department of Health, and U.S. Centers for Disease Control and Prevention, the outbreak persisted. Although concern has been expressed relating to "emergency use" of an , safety has been established in clinical trials and the vaccine is licensed in the European Union and Australia. Vaccine receipt is voluntary, but will be offered to university students and high-risk university-affiliated individuals. Use of the vaccine in this situation has called into question the decision not to distribute the vaccine in the United States. Vaccine manufacturers are currently prioritizing development of a 5-valent vaccine including MenB, and until such time, broader access to Bexsero is considered unlikely.

"While many have also called for wider access to a MenB vaccine, others view Princeton students as test subjects—we want what we cannot have yet also distrust what is unknown," the authors write.

One author disclosed financial ties to Pfizer and Abbott.

Explore further: Princeton to offer meningitis B vaccine to 6,000

More information: Full Text (subscription or payment may be required)

Related Stories

Princeton to offer meningitis B vaccine to 6,000

November 26, 2013
Princeton University says a meningitis vaccine not yet licensed for use in the U.S. will be made available on campus starting Dec. 9 to nearly 6,000 students.

Princeton vaccine reaches 90 percent of eligible

December 13, 2013
Princeton University officials say more than 90 percent of the eligible students and staff received a meningitis vaccine this week as part of the university's effort to halt an outbreak.

Princeton starts mass meningitis B vaccinations (Update 2)

December 9, 2013
Princeton University has begun vaccinating nearly 6,000 students to try to stop an outbreak of type B meningitis in an unusual federal government-endorsed administration of a drug not generally approved for use in the United ...

Princeton U. to give students meningitis B vaccine (Update 2)

November 18, 2013
Princeton University officials decided Monday to make available a meningitis vaccine that hasn't been approved in the U.S. to stop the spread of the sometimes deadly disease on campus.

Bridging the gap: Hope that all Meningitis strains will be vaccinated for

February 27, 2013
Scientists at the University of Southampton have taken a significant and important step in keeping people safe from the most common form of meningitis in the UK.

Princeton students safe to travel despite meningitis outbreak: CDC

November 26, 2013
(HealthDay)—Despite recent outbreaks of bacterial meningitis at Princeton University and the University of California, Santa Barbara, U.S. heath officials said Monday that students are safe to travel home for the Thanksgiving ...

Recommended for you

FDA bans use of opioid-containing cough meds by kids

January 12, 2018
(HealthDay)—Trying to put a dent in the ongoing opioid addiction crisis, the U.S. Food and Drug Administration on Thursday slapped strict new restrictions on the use of opioid-containing cold and cough products by kids.

Taking ibuprofen for long periods found to alter human testicular physiology

January 9, 2018
A team of researchers from Denmark and France has found that taking regular doses of the pain reliever ibuprofen over a long period of time can lead to a disorder in men called compensated hypogonadism. In their paper published ...

Nearly one-third of Canadians have used opioids: study

January 9, 2018
Nearly one in three Canadians (29 percent) have used "some form of opioids" in the past five years, according to data released Tuesday as widespread fentanyl overdoses continue to kill.

Growing opioid epidemic forcing more children into foster care

January 8, 2018
The opioid epidemic has become so severe it's considered a national public health emergency. Addiction to prescription painkillers, such as oxycodone and morphine, has contributed to a dramatic rise in overdose deaths and ...

Price tag on gene therapy for rare form of blindness: $850K

January 3, 2018
A first-of-its kind genetic treatment for blindness will cost $850,000 per patient, making it one of the most expensive medicines in the world and raising questions about the affordability of a coming wave of similar gene-targeting ...

Restasis: Why US consumers paid billions for drug deemed ineffective in other countries

January 2, 2018
Why are Americans, both as patients and taxpayers, paying billions of dollars for a drug whose efficacy is so questionable that it's not approved in the European Union, Australia or New Zealand? Restasis, a blockbuster drug ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.